Number and percentage of potential cases and controls approached who are found to be eligible for the study and reasons for being ineligible (including language) [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Number and percentage of cases and controls approached who sign informed consent [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Number and percentage of cases and controls who complete each part of the study (main questionnaire, diet questionnaire, saliva/buccal specimen) [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Proportion of questions with missing data [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Number and percentage of cases who are willing to have tumor specimens used for future research [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Characteristics of cases and controls (demographics, main risk factors, and use of health care and screening) [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Proportion of participants who rate the study positively on each measure in the post-interview assessment and respondents' suggested changes to the study [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Establish and evaluate procedures for conducting a hospital-based case-control study of risk factors for endometrial cancer in black women.

OUTLINE: This is a multicenter study.

Participants complete questionnaires about lifestyle factors and their usual diet and measure their waist and hips. Saliva or buccal specimens are collected for future research.

PROJECTED ACCRUAL:

A total of 30 cases and 30 controls will be accrued for this study.

Eligibility

Ages Eligible for Study:

21 Years and older (Adult, Senior)

Genders Eligible for Study:

Female

Accepts Healthy Volunteers:

Yes

Sampling Method:

Non-Probability Sample

Study Population

Black women (including African-American, African, Afro-Caribbean women) with endometrial cancer and controls will be recruited at MSKCC, SUNY Downstate Medical Center and Montefiore Medical Center hospitals. Controls will be black (including African-American, African, Afro-Caribbean) women without history of cancer, who have intact uteri, and will be identified in gynecology clinics. Controls will also be recruited at the Breast Examination Center of Harlem (BECH), an affiliate of MSKCC, providing high quality screening services to a minority community.

Criteria

DISEASE CHARACTERISTICS:

Cases

Diagnosed with endometrial cancer within the past year

Self-identified as being black, African-American, black Hispanic, African, or Afro-Caribbean

Healthy controls

Self-identified as being black, African-American, black Hispanic, African, or Afro-Caribbean

No history of endometrial or other cancer (except non-melanoma skin cancer)

No prior hysterectomy

PATIENT CHARACTERISTICS:

Speak English

No medical condition that would make it difficult to complete the interview

PRIOR CONCURRENT THERAPY:

See Disease Characteristics

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00514254